Branched-chain amino acid (BCAA) metabolism is linked to glucose homeostasis, but the underlying signaling mechanisms are unclear. We find that gluconeogenesis is reduced in mice deficient of Ppm1k, a positive regulator of BCAA catabolism, which protects against obesity-induced glucose intolerance. Accumulation of branched-chain keto acids (BCKAs) inhibits glucose production in hepatocytes. BCKAs suppress liver mitochondrial pyruvate carrier (MPC) activity and pyruvate-supported respiration. Pyruvate-supported gluconeogenesis is selectively suppressed in Ppm1k-deficient mice and can be restored with pharmacological activation of BCKA catabolism by BT2. Finally, hepatocytes lack branched-chain aminotransferase that alleviates BCKA accumulation via reversible conversion between BCAAs and BCKAs. This renders liver MPC most susceptible to circulating BCKA levels hence a sensor of BCAA catabolism.
Pubmed ID: 37310861 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets β-Actin
View all literature mentionsThis polyclonal targets BCAT2
View all literature mentionsThis monoclonal targets VDAC (D73D12) Rabbit mAb
View all literature mentionsThis monoclonal targets MPC2
View all literature mentionsThis monoclonal targets mitochondrial pyruvate carrier 1 (MPC1)
View all literature mentionsThis recombinant monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets FBPase
View all literature mentionsThis polyclonal targets PCK1
View all literature mentionsThis polyclonal targets BCKDHA antibody
View all literature mentionsThis polyclonal targets BCKDHA (phospho S293)
View all literature mentionsThis polyclonal targets PPM1K
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentions